Lipocine
LPCN
47 hedge funds and large institutions have $119M invested in Lipocine in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 11 closing their positions.
1,039% more call options, than puts
Call options by funds: $752K | Put options by funds: $66K
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
18% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 11
9% more capital invested
Capital invested by funds: $109M → $119M (+$9.44M)
4% more funds holding
Funds holding: 45 → 47 (+2)
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Carlson Capital
Dallas,
Texas
|
+$2.83M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.41M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$721K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$673K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$596K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VM
VHCP Management
New York
|
-$5.18M |
| 2 |
RA
Royce & Associates
New York
|
-$2.44M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.04M |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$1.23M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$1.05M |
LPCN Hedge Fund Activity: Q4 2015 in Review
47 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q4 2015, worth a combined $119M — up 8.6% from $109M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new LPCN positions and 11 closed out — a net gain of 2 holders — while 14 added to existing stakes and 14 trimmed.
The largest buyer was Carlson Capital, opening a new position worth an estimated $2.83M. The largest seller was VHCP Management, cutting an estimated $5.18M.
- 47 institutional investors held Lipocine (LPCN) as of Q4 2015, up from 45 in Q3 2015.
- Funds reported $119M of Lipocine stock for Q4 2015, up 8.6% quarter-over-quarter.
- 13 funds opened new Lipocine positions in Q4 2015 and 11 closed out, a net change of +2 holders.
- The largest Lipocine buyer in Q4 2015 was Carlson Capital, an estimated $2.83M added.
- The largest Lipocine seller in Q4 2015 was VHCP Management, an estimated $5.18M sold.
Based on aggregated 13F filings for Q4 2015.